Literature DB >> 2985503

Tracheobronchial mucin receptor for Pseudomonas aeruginosa: predominance of amino sugars in binding sites.

S Vishwanath, R Ramphal.   

Abstract

Pseudomonas aeruginosa, a common respiratory tract colonizer and pathogen, adheres to injured tracheal cells and to tracheobronchial mucin. These phenomena suggest that there are specific receptors for this organism in the respiratory tract. The receptor on injured tracheal cells contains n-acetylneuraminic acid as the principal sugar, but the structure of the receptor in mucin has not been described. Using a microtiter plate assay to study bacterial adherence to mucin, we have partially characterized the mucin receptor for P. aeruginosa. The receptor for both nonmucoid and mucoid strains is sensitive to periodate oxidation, suggesting that it is carbohydrate in nature, and the amino sugars n-acetylglucosamine and n-acetylneuraminic acid inhibited the adherence of both types of strains. Nonmucoid strains were more sensitive to inhibition by n-acetylneuraminic acid than to inhibition by n-acetylglucosamine, but the mucoid strains varied in their sensitivities to inhibition by each amino sugar. Preincubation of mucin with heat-inactivated influenza A virus (which binds to neuraminic acid) significantly reduced the adherence of P. aeruginosa. Treatment of mucin with Clostridium perfringens neuraminidase also reduced bacterial adherence significantly. Treatment of mucin with pronase did not affect adherence. Our results suggest that n-acetylglucosamine and n-acetylneuraminic acid are important constituents of the binding sites for P. aeruginosa on human tracheobronchial mucin.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2985503      PMCID: PMC261309          DOI: 10.1128/iai.48.2.331-335.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  The thiobarbituric acid assay of sialic acids.

Authors:  L WARREN
Journal:  J Biol Chem       Date:  1959-08       Impact factor: 5.157

2.  Role of pili in the adherence of Pseudomonas aeruginosa to injured tracheal epithelium.

Authors:  R Ramphal; J C Sadoff; M Pyle; J D Silipigni
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

3.  Airway mucus; production and composition.

Authors:  M T Lopez-Vidriero
Journal:  Chest       Date:  1981-12       Impact factor: 9.410

4.  Adherence of Pseudomonas aeruginosa to human tracheobronchial mucin.

Authors:  S Vishwanath; R Ramphal
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

5.  Attachment and internalization of a Chlamydia trachomatis lymphogranuloma venereum strain by McCoy cells: kinetics of infectivity and effect of lectins and carbohydrates.

Authors:  G Söderlund; E Kihlström
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

6.  Influence of lectins, hexoses, and neuraminidase on the association of purified elementary bodies of Chlamydia trachomatis UW-31 with HeLa cells.

Authors:  S K Bose; G B Smith; R G Paul
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

7.  Immunochemical characterization of the mucoid exopolysaccharide of Pseudomonas aeruginosa.

Authors:  G B Pier; W J Matthews; D D Eardley
Journal:  J Infect Dis       Date:  1983-03       Impact factor: 5.226

8.  Role of Pseudomonas aeruginosa mucoid exopolysaccharide in adherence to tracheal cells.

Authors:  R Ramphal; G B Pier
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

9.  Evidence for mucins and sialic acid as receptors for Pseudomonas aeruginosa in the lower respiratory tract.

Authors:  R Ramphal; M Pyle
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

10.  Identification of an active disaccharide unit of a glycoconjugate receptor for pneumococci attaching to human pharyngeal epithelial cells.

Authors:  B Andersson; J Dahmén; T Frejd; H Leffler; G Magnusson; G Noori; C S Edén
Journal:  J Exp Med       Date:  1983-08-01       Impact factor: 14.307

View more
  26 in total

Review 1.  Recognition of mucin components by Pseudomonas aeruginosa.

Authors:  R Ramphal; S K Arora
Journal:  Glycoconj J       Date:  2001-09       Impact factor: 2.916

Review 2.  The role of bacterial adhesion in cystic fibrosis including the staphylococcal aspect.

Authors:  R Ramphal
Journal:  Infection       Date:  1990 Jan-Feb       Impact factor: 3.553

Review 3.  Microbiology of cystic fibrosis lung infections: themes and issues.

Authors:  J R Govan; J W Nelson
Journal:  J R Soc Med       Date:  1993       Impact factor: 5.344

Review 4.  Lung infections. 3. Pseudomonas aeruginosa and other related species.

Authors:  R Wilson; R B Dowling
Journal:  Thorax       Date:  1998-03       Impact factor: 9.139

5.  Binding of Shigella to rat and human intestinal mucin.

Authors:  R Rajkumar; H Devaraj; S Niranjali
Journal:  Mol Cell Biochem       Date:  1998-01       Impact factor: 3.396

6.  Glycosphingolipid receptors for Pseudomonas aeruginosa.

Authors:  N Baker; G C Hansson; H Leffler; G Riise; C Svanborg-Edén
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

7.  In vivo identification of sialic acid as the ocular receptor for Pseudomonas aeruginosa.

Authors:  L D Hazlett; M Moon; R S Berk
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

8.  Pseudomonas aeruginosa recognizes carbohydrate chains containing type 1 (Gal beta 1-3GlcNAc) or type 2 (Gal beta 1-4GlcNAc) disaccharide units.

Authors:  R Ramphal; C Carnoy; S Fievre; J C Michalski; N Houdret; G Lamblin; G Strecker; P Roussel
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

9.  Adhesion of Pseudomonas aeruginosa pilin-deficient mutants to mucin.

Authors:  R Ramphal; L Koo; K S Ishimoto; P A Totten; J C Lara; S Lory
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

10.  Human tracheobronchial mucin: purification and binding to Pseudomonas aeruginosa.

Authors:  M S Reddy
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.